(410 ILCS 620/17) (from Ch. 56 1/2, par. 517)
Sec. 17.
(a) No person shall sell, deliver, offer for sale, hold for
sale or give away any new drug unless (1) an application with respect thereto
has been
approved and the approval has not been withdrawn under Section 505 of the
Federal Act, and (2) a copy of the letter of approval or approvability
issued by the Federal Food and Drug Administration is on file with the
Director, if the product is manufactured in the State of Illinois.
(b) No person shall use in human beings or animals a new drug or new
animal drug limited to investigational use unless the person has filed
with the Federal Food
and Drug Administration a completed and signed "Notice of
claimed investigational exemption for a new drug" form in accordance with
Section 312.1 of Title 21 of the Code of Federal Regulations (1980) and
the exemption has not been terminated. The drug shall be plainly labeled
in compliance with
Section 505(i) or 507(d) of the Federal Act.
(c) This Section shall not apply:
(1) to any drug which is not a new drug as defined in the Federal Act;
or
(2) to any drug which is licensed under the Public Health Service Act of
July 1, 1944 or under the animal virus-serum-toxin law of March 4, 1913; or
(3) to any drug which is subject to Section 15(l) of this Act.
(Source: P.A. 84-891.)
|